Navigation Links
Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
Date:7/17/2014

s well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while Amgen and its partners routinely obtain patents for their products and technology, the protection of our products offered by patents and patent applications may be challenged, invalidated or circumvented by our or our partners' competitors and there can be no guarantee of our or our partners' ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to integrate the operations of companies we have acquired may not be successful.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative.  Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates.

CONTACT: Amgen, Thousand Oaks
Kristen Davis, 805-447-3008 (media)
Arvind Sood, 805-447-
'/>"/>

SOURCE Amgen
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease
2. Amgen To Present At The 32nd Annual J.P. Morgan Healthcare Conference
3. Chief Financial Officer Jonathan M. Peacock to Leave Amgen; Company Appoints Michael A. Kelly Acting Chief Financial Officer
4. Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol
5. Amgen Announces 2014 First Quarter Dividend
6. Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
7. Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013
8. Amgens Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94
9. Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
10. Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
11. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is ... ® Complete Knee System. , ... year since Zimmer first introduced the NexGen knee system, ... more than five million implantations of the NexGen knee have ... NexGen knee demonstrates the importance of design innovation and component ...
(Date:3/27/2015)... March 27, 2015 XRpro Sciences, Inc., ... discovery and development services which features high throughput ... industry, announced financial results for the year ended ...  Tyson, Chairman of XRpro Sciences commented, "We have ... from development stage to commercial stage in large ...
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... 2011 The Consumer Healthcare Products Association (CHPA) ... North Carolina legislature passing a real-time, stop-sale system ... effective medicines containing pseudoephedrine (PSE), while stopping sales ... passage of a real-time, stop-sale system is a ...
... 2011 SmallCapVoice.com, Inc. announced today that ... Medical Equipment, Inc. (Pinksheets: SHOM), a holding ... durable medical equipment to medical institutions, is ... at http://smallcapvoice.com/blog/6-14-11-audio-interview-with-southern-home-medical-equipment-inc-pink-sheets-shom . SmallCapVoice ...
Cached Medicine Technology:A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 2A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 3
(Date:3/28/2015)... Genomic medicine experts have sequenced the genomes of ... time, key information for understanding and treating this intractable ... story on the Surviving Mesothelioma website. , ... British Columbia Cancer Agency, and PhenoPath lab in Seattle, ... and mutations that can lead to peritoneal mesothelioma ...
(Date:3/28/2015)... 28, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Physical Therapy Association Annual Conference to be held ... Hotel in Columbus, OH. , The OPTA ... exhibits with products and services. , Representatives ...
(Date:3/28/2015)... Viejo, California (PRWEB) March 28, 2015 ... announced a new overlay entitled Scratches 5K from Pixel ... grungy scratch effects to any media inside Final Cut ... Studios. “StoryBoard Corporate saves time and is an effective ... media using FCPX Overlay Scratches 5K's intuitive grunge overlays. ...
(Date:3/28/2015)... 28, 2015 Servpro of Paso ... week released a report about the link between mold ... sufferers, and according to recent medical research, may even ... to the Environmental Protection Agency, people with sensitivity to ... in mold may trigger asthma attacks for asthma sufferers. ...
(Date:3/27/2015)... 27, 2015 Wellness for Cancer–the first ... criteria for the spa and wellness industry–has certified Hands ... have experienced or are living with cancer. Hands ... 365® Network, will be identified with a special Wellness ... provider of safe, therapeutic services for cancer patients. , ...
Breaking Medicine News(10 mins):Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4
... R.I. [Brown University] A study published online Oct. 18 ... provides some new but qualified support for the idea that ... of developing deadly brain tumors. People with somewhat elevated ... the body,s immune response to allergens, were significantly less likely ...
... TUESDAY, Oct. 18 (HealthDay News) -- In an important first, ... of malaria in young African children by about half, according ... in this Phase 3 trial is far less than the ... illnesses in the West, the findings are promising, given that ...
... by researchers at the University of Pennsylvania,s schools of ... vaccine of its kind that shows an increase in ... work shows for the first time the feasibility and ... be employed in the treatment of a number of ...
... (UH) has invited best-selling author and noted physician Abraham Verghese ... Health and Human Values at 7:30 p.m., Monday, Oct. 24 ... an Indian-American immigrant to the United States, Dr. Verghese,s varied ... new India studies program at UH," said Lois Zamora, chair ...
... a large-scale Phase III trial of RTS,S*, published online today ... show the malaria vaccine candidate to provide young African children ... acceptable safety and tolerability profile. The results were announced today ... Gates Foundation in Seattle, Washington. Half the world,s population ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay ... conventional Pap tests as a cervical cancer screening tool ... The U.S. Preventive Services Task Force ... researchers are now seeking to fine-tune these guidelines. The ...
Cached Medicine News:Health News:More evidence that allergies may help in fighting brain tumors 2Health News:Promising Malaria Vaccine May Save Children's Lives 2Health News:Promising Malaria Vaccine May Save Children's Lives 3Health News:Promising Malaria Vaccine May Save Children's Lives 4Health News:Penn researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine 2Health News:Penn researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine 3Health News:Dr. Abraham Verghese to give John P. McGovern Lecture on Oct. 24 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 3Health News:Pap Test Still Best for Cervical Cancer Screening, Experts Say 2Health News:Pap Test Still Best for Cervical Cancer Screening, Experts Say 3
... Ultracompact high end desktop multilaser flow cytometer ... kind of cell analysis and absolute counting. ... and two different side scatter signals in ... The new CyFlow ML instrument can perform ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
The Elecsys 2010 Rack System streamlines processes and allows for smooth implementation of laboratory automation....
Medicine Products: